TrialEye (London, England)2023

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial.

Sunil S Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.